acepreval and Dermatitis--Atopic

acepreval has been researched along with Dermatitis--Atopic* in 1 studies

Other Studies

1 other study(ies) available for acepreval and Dermatitis--Atopic

ArticleYear
Features and prognoses of infantile patients with atopic dermatitis hospitalized for severe complications.
    The Journal of dermatology, 2006, Volume: 33, Issue:12

    Although atopic dermatitis (AD) itself is regarded as a non-life threatening disease, childhood AD may be rarely accompanied by some serious complications. Six infantile AD patients who were hospitalized because of severe systemic complications, in addition to severe dermatitis on almost the entire body surface, are described. They were complicated by hypoproteinemia, hypovolemia, thrombocytosis, reduced serum immunoglobulin G, elevated serum liver enzymes and growth retardation. They had not been treated with topical corticosteroid before hospitalization. They were treated with topical corticosteroid and their eruption remarkably improved within 20 days (median) of hospitalization. Most of the abnormal clinical data including platelet numbers, serum levels of total protein, and liver enzymes had become normal at the day of discharge. After 30 +/- 4 months of follow up, their skin condition was fair with daily application of moisturizer and occasional use of topical corticosteroid, without any systemic problems. Although severe infantile AD may be accompanied by potentially life-threatening systemic complications, their prognoses concerning AD are favorable if they are treated adequately from the beginning of their infancy.

    Topics: Administration, Cutaneous; Alanine Transaminase; Anti-Inflammatory Agents; Aspartate Aminotransferases; Blood Proteins; Dermatitis, Atopic; Dermatologic Agents; Female; Follow-Up Studies; Growth Disorders; Hospitalization; Humans; Hypoproteinemia; Hypovolemia; Immunoglobulin G; Infant; Liver; Male; Platelet Count; Prednisolone; Prognosis; Serum Albumin; Thrombocytosis

2006